Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Epsilon Health Investors
AddedFeb 15, 2024
UpdatedJun 28, 2026
Epsilon Health Investors

Epsilon Health Investors

Operating

Epsilon Health Investors: A healthcare-focused venture capital firm serving regional non-profit health.

Location
Washington, D.C., DC, US
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Epsilon Health Investors is a digital healthcare-focused venture capital firm managing capital for strategic limited partners and commercial investors. The firm typically invests in seed, Series A, and Series B rounds, with a focus on innovative healthcare technology solutions. Epsilon leverages its strategic LP base and deep industry experience to support portfolio companies.

Founded by healthcare veterans Steven Epstein and Gregory Epstein of Epstein Becker & Green, P.C., Epsilon brings decades of healthcare investing, advising, regulatory support, and board leadership expertise. Notable portfolio companies include AvoMD, Axuall, and Marigold Health. The firm's unique value proposition lies in its founders' extensive relationships and industry knowledge, providing portfolio companies with strategic guidance and support.

Epsilon Health Investors - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments4
Current Portfolio Count4
Total Portfolio Exits0

Top Investment Stages

Seed2 (50.0%)
Series A1 (25.0%)
Series B1 (25.0%)

Stage Mix

Seed 50%Series A 25%Series B 25%

Concentration shown as share of disclosed investments by stage.

Recent Investments

AvoMD logo

AvoMD

Axuall logo

Axuall

Marigold Health logo

Marigold Health

Banjo Health logo

Banjo Health

Epsilon Health Investors - Similar Investment Firms

Health2047 Capital Partners logo

Health2047 Capital Partners

HealthX Management logo

HealthX Management

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Healthy Ventures logo

Healthy Ventures

healthy.vc

Echo Health Ventures logo

Echo Health Ventures

HealthInvest Equity Partners logo

HealthInvest Equity Partners

Ambit Health Ventures logo

Ambit Health Ventures

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

VentureHealth logo

VentureHealth

venturehealth.com

Venture Investors logo

Venture Investors

Excelerate Health Ventures logo

Excelerate Health Ventures

HealthTech Capital logo

HealthTech Capital

Lrvhealth logo

Lrvhealth

lrvhealth.com

Evidity Health Capital logo

Evidity Health Capital

evidity.com

Health Enterprise Partners logo

Health Enterprise Partners

hepfund.com

Epsilon Health Investors - Classification

Also Known As
  • Epsilon Health Investors, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 10 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 8000Health Services
  • 6790Miscellaneous Investing
  • 8040Offices And Clinics Of Other Health Practitioners
  • 6799Investors, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified